Mini-Reviews in Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 20 Issue: 10
Author(s): Claudio Viegas
Affiliation:
Export Options
About this article
Cite this article as:
Viegas Claudio , Meet Our Editorial Board Member, Mini-Reviews in Medicinal Chemistry 2020; 20 (10) . https://dx.doi.org/10.2174/138955752020200430074527
DOI https://dx.doi.org/10.2174/138955752020200430074527 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
5
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry Creation of a putative third metal binding site in type II dihydroorotases significantly enhances enzyme activity
Protein & Peptide Letters Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism
Current Medicinal Chemistry Recognition of Nucleic Acid Ligands by Toll-Like Receptors 7/8: Importance of Chemical Modification
Current Medicinal Chemistry Vitamin D and Subjective Memory Complaint in Community-Dwelling Older Adults
Current Alzheimer Research Regulation of Mitochondrial Biogenesis in Metabolic Syndrome
Current Drug Targets Pixuvri<sup>®</sup> (Pixantrone Dimaleate, BBR 2778): From Lab to Market
Current Organic Chemistry B Cell Depletion in Systemic Vasculitis
Current Immunology Reviews (Discontinued) Effects of an Outpatient Service Rehabilitation Programme in Patients Affected by Pulmonary Arterial Hypertension: An Observational Study
Cardiovascular & Hematological Disorders-Drug Targets Therapeutic Targets for the Treatment of Comorbidities Associated with Epilepsy
Current Molecular Pharmacology Advances in the Treatment of Neurodegenerative Disorders Employing Nanoparticles
Recent Patents on Drug Delivery & Formulation The Management of Phosphodiesterase-5 (PDE5) Inhibitor Failure
Current Vascular Pharmacology The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders
CNS & Neurological Disorders - Drug Targets Chinese Medicine in Inhalation Therapy: A Review of Clinical Application and Formulation Development
Current Pharmaceutical Design Vaccine Therapy for Hepatitis B Virus Carrier
Current Drug Targets - Infectious Disorders Orally Administrated Small Molecule Drugs with Intestine Targeted Profile: Recent Development and Prospects
Current Medicinal Chemistry The Importance of Melatonin and Mitochondria Interaction in Mood Disorders and Schizophrenia: A Current Assessment
Current Medicinal Chemistry Focusing on the Interactions between the GABAergic System and Neurosteroids in Neurodevelopmental Disorders
Current Pharmaceutical Design Actionable Nutrigenetics for Genetically Based Diseases? A New Critical Path to P4 Medicine
Current Pharmacogenomics and Personalized Medicine Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry